Stay updated on Depemokimab in Severe Asthma Clinical Trial
Sign up to get notified when there's something new on the Depemokimab in Severe Asthma Clinical Trial page.

Latest updates to the Depemokimab in Severe Asthma Clinical Trial page
- Check2 days agoChange DetectedAdded a publication entry related to the study, including a PubMed note for a related article (Safety and Tolerability of Twice-Yearly Depemokimab...). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded a comprehensive Locations section listing trial sites by state/province (US, Australia, Canada) and updated the page to Revision: v3.3.3. Removed the prior v3.3.2 entries, including the old location listings and the HHS Vulnerability Disclosure link.SummaryDifference1%

- Check24 days agoNo Change Detected
- Check45 days agoChange DetectedAdded Revision: v3.3.2 and removed Revision: v3.2.0.SummaryDifference0.0%

- Check52 days agoChange DetectedAdded a new trial site in Tainan, Taiwan (704) and updated the existing listing to display the location as Tainan (704) instead of Tainan City, Taiwan.SummaryDifference0.2%

- Check66 days agoChange DetectedThe Study Record Dates section now shows the Results First Posted date (2024-11-29). Other study details remain unchanged.SummaryDifference0.2%

- Check95 days agoChange DetectedUpdated the page to v3.2.0 with a prominent notice about potential data/tansaction delays due to funding gaps and where to check operating status; previous v3.1.0 reference removed.SummaryDifference2%

Stay in the know with updates to Depemokimab in Severe Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Depemokimab in Severe Asthma Clinical Trial page.